Ohio State Navbar

News


Dr. Byrd named Associate Editor of Blood


February 20, 2014

Dr. John Byrd named Associate Editor of Blood. The rest of the story



Ibrutinib Approved For CLL Treatment By FDA


February 12, 2014

Ibrutinib approved for CLL Treatment The rest of the story



Dr. Woyach, Dr. Johnson, and Dr. Byrd Receive Alliance BTK RO1 Grant from the NIH


January 17, 2014

Dr. Woyach, Dr. Johnson, and Dr. Byrd Receive Alliance BTK RO1 Grant from the NIH for "Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies." The rest of the story



Dr. Johnson and Dr. Byrd Recieve BTK RO1 Grant from the NIH


January 17, 2014

Co-PI's Dr. Amy Johnson and Dr. John Byrd receive a RO1 grant for "Targeted Therapy for Lymphoid Malignancies." The rest of the story



Ta-Ming Liu receives Pelotonia Graduate Fellowship


June 07, 2012

Ta-Ming Liu receives Pelotonia Graduate Fellowship The rest of the story



Danielle Chappell receives Pelotonia Undergraduate Fellowship


June 07, 2012

Danielle Chappell receives Pelotonia Undergraduate Fellowship The rest of the story



Dr. Woyach receives James V. Warren Award


May 29, 2012

Dr. Woyach, a Medical Fellow at the James Cancer Institute has been chosen as the 2012 James V. Warren Award Recipient. The rest of the story



Dr. Yeh recieves Pelotonia Fellowship Award


October 23, 2011

Yuh-Ying Yeh, PhD, receives Pelontonia Fellowship Award. The rest of the story



Dr. Byrd and Dr. Lapalombella Receive Translational Research Grant


July 22, 2011

Dr. Lapalombella receives an LLS Translational Research Grant. The rest of the story



Dr. Byrd and CLL Experimental Therapeutics Lab featured on 10TV news for promising new drug to treat CLL


June 21, 2011

Local News Story The rest of the story



Next